GeneCentric Therapeutics
GeneCentric Therapeutics is uses their rT(I)ME Explorer Platform to identify high resolution molecular subtypes and drug responder populations that enable the development of precision cancer drugs while improving patient outcomes. GeneCentric Therapeutics was founded in 2011 and based in Durham, North Carolina.
Last updated on
About GeneCentric Therapeutics
Founded
2011Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$41MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
DurhamState
North CarolinaCountry
United StatesGeneCentric Therapeutics
Find your buyer within GeneCentric Therapeutics
Tech Stack (54)
